Search Page

1

Cite

Share

Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma.

Azmi AS, Khan HY, Muqbil I, Aboukameel A, Neggers JE, Daelemans D, Mahipal A, Dyson G, Kamgar M, Al-Hallak MN, Tesfaye A, Kim S, Shidham V, M Mohammad R, Philip PA. Azmi AS, et al. Among authors: dyson g. Clin Cancer Res. 2020 Mar 15;26(6):1338-1348. doi: 10.1158/1078-0432.CCR-19-1728. Epub 2019 Dec 12. Clin Cancer Res. 2020. PMID: 31831564 Free PMC article. Clinical Trial.

Cite

Share

2

Cite

Share

Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells.

Teslow EA, Mitrea C, Bao B, Mohammad RM, Polin LA, Dyson G, Purrington KS, Bollig-Fischer A. Teslow EA, et al. Among authors: dyson g. Mol Oncol. 2019 Apr;13(4):894-908. doi: 10.1002/1878-0261.12444. Epub 2019 Mar 1. Mol Oncol. 2019. PMID: 30636104 Free PMC article.

Cite

Share

3

Cite

Share

PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors.

Mpilla G, Aboukameel A, Muqbil I, Kim S, Beydoun R, Philip PA, Mohammad RM, Kamgar M, Shidham V, Senapedis W, Baloglu E, Li J, Dyson G, Xue Y, El-Rayes B, Azmi AS. Mpilla G, et al. Among authors: dyson g. Cancers (Basel). 2019 Nov 29;11(12):1902. doi: 10.3390/cancers11121902. Cancers (Basel). 2019. PMID: 31795447 Free PMC article.

Cite

Share

4

Cite

Share

A stroma-corrected ZEB1 transcriptional signature is inversely associated with antitumor immune activity in breast cancer.

Block CJ, Dyson G, Campeanu IJ, Watza D, Ratnam M, Wu G. Block CJ, et al. Among authors: dyson g. Sci Rep. 2019 Nov 28;9(1):17807. doi: 10.1038/s41598-019-54282-z. Sci Rep. 2019. PMID: 31780722 Free PMC article.

Cite

Share

5

Cite

Share

COPD-dependent effects of genetic variation in key inflammation pathway genes on lung cancer risk.

Watza D, Lusk CM, Dyson G, Purrington KS, Wenzlaff AS, Neslund-Dudas C, Soubani AO, Gadgeel SM, Schwartz AG. Watza D, et al. Among authors: dyson g. Int J Cancer. 2020 Aug 1;147(3):747-756. doi: 10.1002/ijc.32780. Epub 2019 Dec 12. Int J Cancer. 2020. PMID: 31709530 Free PMC article.

Cite

Share

6

Cite

Share

Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer.

Bao B, Teslow EA, Mitrea C, Boerner JL, Dyson G, Bollig-Fischer A. Bao B, et al. Among authors: dyson g. Mol Cancer Res. 2020 Dec;18(12):1803-1814. doi: 10.1158/1541-7786.MCR-20-0359. Epub 2020 Sep 10. Mol Cancer Res. 2020. PMID: 32913111

Cite

Share

7

Cite

Share

Diversity Outbred Mice Reveal the Quantitative Trait Locus and Regulatory Cells of HER2 Immunity.

Wei WZ, Gibson HM, Jacob JB, Frelinger JA, Berzofsky JA, Maeng H, Dyson G, Reyes JD, Pilon-Thomas S, Ratner S, Wei KC. Wei WZ, et al. Among authors: dyson g. J Immunol. 2020 Sep 15;205(6):1554-1563. doi: 10.4049/jimmunol.2000466. Epub 2020 Aug 12. J Immunol. 2020. PMID: 32796024

Cite

Share

8

Cite

Share

CLCA2 expression is associated with survival among African American women with triple negative breast cancer.

Purrington KS, Knight J 3rd, Dyson G, Ali-Fehmi R, Schwartz AG, Boerner JL, Bandyopadhyay S. Purrington KS, et al. Among authors: dyson g. PLoS One. 2020 Apr 16;15(4):e0231712. doi: 10.1371/journal.pone.0231712. eCollection 2020. PLoS One. 2020. PMID: 32298355 Free PMC article.

Cite

Share

9

Cite

Share

Heritable Susceptibility to Breast Cancer among African-American Women in the Detroit Research on Cancer Survivors Study.

Purrington KS, Raychaudhuri S, Simon MS, Clark J, Ratliff V, Dyson G, Craig DB, Boerner JL, Beebe-Dimmer JL, Schwartz AG. Purrington KS, et al. Among authors: dyson g. Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2369-2375. doi: 10.1158/1055-9965.EPI-20-0564. Epub 2020 Aug 31. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32868316 Free PMC article.

Cite

Share

10

Cite

Share

Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.

Dzinic SH, Mahdi Z, Bernardo MM, Vranic S, Beydoun H, Nahra N, Alijagic A, Harajli D, Pang A, Saliganan DM, Rahman AM, Skenderi F, Hasanbegovic B, Dyson G, Beydoun R, Sheng S. Dzinic SH, et al. Among authors: dyson g. PLoS One. 2019 Apr 19;14(4):e0215089. doi: 10.1371/journal.pone.0215089. eCollection 2019. PLoS One. 2019. PMID: 31002675 Free PMC article.

Cite

Share